Target intelligence / Profile preview

Daboia siamensis C-type lectin-like protein (Snaclec) (Snaclec)

Target
Snaclec
Molecular classification
C-type lectin, Snake venom toxin, Protein
01

Overview

Daboia siamensis C-type lectin-like proteins, or snaclecs, are a major class of non-enzymatic toxins found in the venom of the Eastern Russell's viper (Daboia siamensis). These proteins typically exist as disulfide-linked heterodimers that share structural homology with the carbohydrate-recognition domains of C-type lectins but lack the residues necessary for calcium-dependent sugar binding (UniProt, 2024). Instead, they function by binding with high affinity to various blood components, including platelet receptors like glycoprotein Ib (GPIb) and glycoprotein VI (GPVI), as well as coagulation factors such as Factor IX and Factor X (PubMed, 2021). This binding can either induce or inhibit platelet aggregation, contributing significantly to the systemic hemotoxicity, thrombocytopenia, and venom-induced consumption coagulopathy (VICC) observed in snakebite victims (WHO, 2016). In clinical management, these proteins are the primary targets for therapeutic antivenoms, which utilize polyclonal antibodies to neutralize the toxins and restore normal hemostatic function. Beyond their pathological role, they are valuable tools in hematological research for characterizing platelet signaling pathways and developing diagnostic assays for bleeding disorders. Their ability to target specific receptors with high precision also makes them templates for the design of novel anticoagulant and antiplatelet therapeutics (PubChem, 2024).

Other names
SnaclecsC-type lectin-like proteinsCLPsRussell's viper C-type lectinsSnake C-type lectins
02

Mechanism of action

Neutralization of toxin activity via antibody-mediated binding, preventing interaction with physiological substrates like platelets and coagulation factors.

03

Biological functions

Platelet aggregationBlood coagulationHemostasis modulationCell adhesion
04

Disease associations

Snakebite envenomationCoagulopathyThrombocytopeniaHemorrhage
05

Safety considerations

AnaphylaxisSerum sicknessIncomplete neutralization of venom toxins
06

Interacting drugs

Daboia siamensis Monovalent Antivenom

1 more in the full profile.

07

Biomarkers

Platelet countProthrombin time (PT)Fibrinogen levelsVenom antigen levels (ELISA)

Beyond the preview

Go deeper on Daboia siamensis C-type lectin-like protein (Snaclec) (Snaclec).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daboia siamensis C-type lectin-like protein (Snaclec) (Snaclec).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call